Canada pauses use of AstraZeneca under 55 / Also Germany B/c Deaths 30/03/21

30/03/21
Canada pauses use of AstraZeneca vaccine in people under 55

Canada has suspended its use of AstraZeneca’s coronavirus vaccine for those younger than 55, pointing to safety concerns following a number of reports of serious blood clotting among recipients in Europe.

The recommendation was prompted by new data out of Europe suggesting the risk of blood clotting in AstraZeneca recipients could be as high as one in 100,000, far above the one in 1 million figure previously estimated by researchers, Deeks said. She added that most of the European patients experiencing clotting were women under the age of 55, and that the fatality rate among those who develop blood clots is as high as 40%.

+
30/03/21
Germany -
Major hospitals in Germany have suspended the use of the Oxford-AstraZeneca vaccine for women under the age of 60 over fears it may cause dangerous blood clots.

Germany's vaccine regulator said on Tuesday it has recorded 31 cases of a rare blood clot in the brain, nine of which resulted in deaths, after people received a COVID-19 vaccine from AstraZeneca